<\/p>\n
\ud83d\udca1 Raskt svar<\/strong><\/p>\n Dutas-T<\/strong> kombinerer tamsulosin 0,4 mg<\/strong> (an alpha-blocker for immediate urinary symptom relief) with dutasteride 0.5 mg<\/strong> (a dual 5-alpha-reductase inhibitor that shrinks the prostate over 3\u20136 months). This dual-MOA single-capsule approach is preferred for men with moderate\u2013severe BPH, enlarged prostates (>40 mL), or at risk of acute urinary retention. Once-daily dosing.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n Dutas-T is a fixed-dose combination capsule containing tamsulosin hydrochloride 0.4 mg + dutasteride 0.5 mg<\/strong>. The combination attacks BPH via two complementary mechanisms:<\/p>\n The CombAT (Combination of Avodart and Tamsulosin) trial showed this combination reduced BPH progression, acute urinary retention, and surgery need more than either drug alone. Available strength: 0.4 mg tamsulosin + 0.5 mg dutasteride<\/strong>. Manufactured by Dr. Reddy's Laboratories.<\/p>\n Tamsulosin-related:<\/strong> dizziness, headache, abnormal ejaculation, rhinitis, asthenia.<\/p>\n Dutasteride-related:<\/strong> decreased libido (~4%), erectile dysfunction (~4%), reduced ejaculate volume, gynecomastia, mood changes.<\/p>\n Alvorlige (sjeldne):<\/strong> orthostatic hypotension, Intraoperative Floppy Iris Syndrome, priapism, persistent sexual side effects after discontinuation (PFS-equivalent).<\/p>\n The CombAT trial (4-year outcomes) showed combination therapy reduced BPH clinical progression by ~66% vs dutasteride alone and ~41% vs tamsulosin alone. Combination is preferred when prostate is enlarged (>30\u201340 mL) or PSA is elevated, suggesting ongoing glandular growth. For smaller prostates with pure symptom dominance, tamsulosin monotherapy is often sufficient.<\/p>\n Se ogs\u00e5: Urimax-F<\/a> (tamsulosin + finasteride alternative) and our Finasteride vs Dutasteride Guide<\/a>.<\/p>\n Store at room temperature (15\u201330 \u00b0C \/ 59\u201386 \u00b0F), away from moisture and heat. Do not refrigerate. Keep in original blister. Keep away from women of reproductive age.<\/p>\n Tamsulosin and dutasteride attack BPH by different mechanisms \u2014 smooth-muscle relaxation and DHT suppression. Combination therapy reduces BPH progression more than either drug alone (CombAT trial).<\/p>\n Tamsulosin gives urinary symptom relief within 1\u20132 weeks. Dutasteride takes 3\u20136 months for prostate shrinkage. Full combination benefit is seen at 6\u201312 months.<\/p>\n For prostates under 30 mL without risk factors, tamsulosin monotherapy often suffices. Combination is strongest for prostates 30 mL and above or men with elevated PSA, bothersome symptoms, and BPH-progression risk factors.<\/p>\n The dutasteride component contributes decreased libido (~4%) and erectile dysfunction (~4%) risk. The tamsulosin component contributes retrograde ejaculation. Discuss risk-benefit with a clinician, particularly if sexual function is a priority.<\/p>\n No \u2014 BPH is progressive and symptoms return over weeks to months. Dutasteride has a 5-week half-life, so its effect clears slowly; tamsulosin effect ends within days. For safe discontinuation, discuss with a clinician.<\/p>\n With care. Tamsulosin + sildenafil\/vardenafil = additive hypotension risk. Tadalafil 5 mg daily is often preferred \u2014 it also treats BPH symptoms on its own.<\/p>\n Dutasteride halves PSA readings. Always tell your clinician you are on Dutas-T before any PSA test. Convention is to double the measured PSA for interpretation.<\/p>\n Not directly. The REDUCE trial suggested dutasteride reduced low-grade prostate cancer risk but slightly raised detection of high-grade tumours. Use dutasteride for BPH indications \u2014 not as prostate cancer prophylaxis.<\/p>\n \u2695\ufe0f Medisinsk ansvarsfraskrivelse:<\/strong> Denne informasjonen er utdanningsmessig og erstatter ikke medisinsk r\u00e5dgivning. Konsulter en kliniker f\u00f8r du starter, stopper eller endrer noen medikamenter. Reseptbelagte produkter b\u00f8r kun brukes under medisinsk tilsyn.<\/p>\n<\/div>\n Se ogs\u00e5:<\/strong> oral minoxidil (Minoxytop)<\/strong><\/a> \u2014 oral minoxidil for de som ikke responderer p\u00e5 topikal behandling \u2014 Curatio Healthcare 1,25 \/ 2,5 \/ 5 mg tabletter.<\/p>\n <\/p>\n Andre produkter innen Menns helse<\/strong> som kunder ogs\u00e5 ser p\u00e5:<\/p>\n \u2705 Forbedrer urinstr\u00f8m Dutas T contains Tamsulosin and Dutasteride.<\/p>","protected":false},"featured_media":61711,"comment_status":"closed","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3202,3141,3142],"product_tag":[5081,3474,3473],"class_list":{"0":"post-61710","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-benign-prostatic-hyperplasia-bph-treatment","7":"product_cat-category-overview","8":"product_cat-mens-health","9":"product_tag-dutas-t","10":"product_tag-dutasteride","11":"product_tag-tamsulosin","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/61710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=61710"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/61711"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=61710"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=61710"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=61710"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=61710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Hvorfor bestille fra MedsBase<\/h3>\n
What Is Dutas-T?<\/strong><\/h2>\n
\n
Klinisk bruk<\/strong><\/h2>\n
\n
Hvordan ta<\/strong><\/h2>\n
\n
Bivirkninger<\/strong><\/h2>\n
Who Should Not Take Dutas-T<\/strong><\/h2>\n
\n
Legemiddelinteraksjoner<\/strong><\/h2>\n
\n
Combination vs Monotherapy<\/strong><\/h2>\n
Oppbevaring<\/strong><\/h2>\n
Vanlige sp\u00f8rsm\u00e5l<\/h2>\n
Why the combination pill?<\/h3>\n
How soon will symptoms improve?<\/h3>\n
Is there a size below which combination is unnecessary?<\/h3>\n
What about sexual side effects?<\/h3>\n
Can I stop taking Dutas-T abruptly?<\/h3>\n
Can I combine Dutas-T with a PDE5 inhibitor?<\/h3>\n
Hva med PSA-overv\u00e5kning?<\/h3>\n
Will Dutas-T prevent prostate cancer?<\/h3>\n
Relaterte BPH-produkter<\/h3>\n
\n
Relaterte alternativer<\/h3>\n
\n
\n\u2705 Reduserer prostata st\u00f8rrelse
\n\u2705 Lindrer urinveisplager
\n\u2705 Behandler godartet prostatahyperplasi
\n\u2705 Enhances prostate health<\/p>\n